STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and moreWorldPing
Image via STAT.

What happened

The U.S.is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs…

Key facts

  • Reported by STAT and published Fri, 18 Sep 2026 13:29:38 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Follow the story

Living hubs that keep updating as this story develops.

Related WorldPing coverage

The Verge
WorldPing
The Verge

What Hollywood thinks about existential AI warnings

As the tech sector sounds alarms about AI's potential to destroy humanity, entertainment labor groups are urging the public to stay focused on what's already happening.

Brief by WorldPing · Original reporting by The Verge